Role of FDG PET in Implementation of Involved-Node Radiation Therapy for Hodgkin's Lymphoma Patients

Girinsky T, Aupérin A, Ribrag V, Elleuch M, Fermé C, Bonniaud G, Ruelle C, Alberini JL7, Celebic A, Edeline V |  01.08.2014

This study examines the value of 18F FDG PET in achieving precision in the implementation of involved-node radiation therapy in patients treated for clinical stages (CS) I/II supradiaphragmatic Hodgkin's lymphoma.

Related Articles